MFG
BIO icon

Magnus Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Magnus Financial Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-874
Closed -$395K – 348
2020
Q2 		$395K Hold
874
– – 0.04% 227
2020
Q1 		$306K Hold
874
– – 0.04% 267
2019
Q4 		$323K Hold
874
– – 0.05% 270
2019
Q3 		$291K Hold
874
– – 0.05% 265
2019
Q2 		$273K Buy
874
+30
+4% +$8.98K 0.05% 297
2019
Q1 		$258K Buy
+844
New +$228K 0.05% 308

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Magnus Financial Group's BIO Position: Q3 2020 in Review

Magnus Financial Group sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2020, closing a stake of 874 shares — an estimated $395K sold.

Magnus Financial Group first reported a position in BIO in Q1 2019 and held it in 6 quarters. The position peaked at $395K in Q2 2020. 479 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • Magnus Financial Group reported no remaining Bio-Rad Laboratories Class A position as of Q3 2020 after selling out during the quarter.
  • Magnus Financial Group sold 874 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $395K.
  • Magnus Financial Group first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 6 quarters.
  • Magnus Financial Group's Bio-Rad Laboratories Class A position peaked at $395K in Q2 2020.
  • 479 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on Magnus Financial Group's 13F filing for Q3 2020, filed 5 Nov 2020.